MitHPPK/DHPS Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Validation Data

Commercial antibodies validated for DHPS detection show cross-reactivity with mitHPPK/DHPS due to conserved epitopes:

Antibody IDHost/IsotypeReactivityApplicationsObserved MWKey Validations
11184-1-AP Rabbit IgGHuman, Mouse, RatWB, IP, IF, IHC35–40 kDaConfirmed in HeLa, NIH/3T3 cells
A30637 Rabbit IgGHuman, Mouse, RatWB, ELISA72 kDaTested in K562, HUVEC, NIH/3T3
67998-1-Ig Mouse IgG1HumanWB, ELISA41 kDaVerified in HEK-293, LNCaP cells
ab202133 Rabbit IgGHuman, Mouse, RatWB41 kDaCited in 2 peer-reviewed studies

Key disparities in observed molecular weights (35–72 kDa) suggest isoform-specific detection or post-translational modifications.

Folate Biosynthesis Studies

  • Structural analyses using mitHPPK/DHPS antibodies revealed its role in herbicidal targeting, with sulfonamide inhibitors showing cross-kingdom efficacy against plant and microbial forms .

  • In Arabidopsis, mitHPPK/DHPS knockout is lethal, while cytosolic forms regulate stress responses .

Inflammation and Metabolism

  • DHPS hypusinates eIF5A, promoting proinflammatory M1 macrophage polarization. Antibodies enabled quantification of DHPS-eIF5A complexes in obese adipose tissue, linking enzyme activity to glucose intolerance .

  • Myeloid-specific Dhps knockout mice showed reduced adipose M1 macrophages and improved insulin sensitivity .

Technical Considerations

  • Dilution optimization: WB concentrations range from 1:200 (polyclonal ) to 1:50,000 (monoclonal ).

  • Sample preparation: Mitochondrial fractionation is critical for mitHPPK/DHPS detection, as cytosolic isoforms may cross-react .

  • Validation controls: Peptide blocking experiments (e.g., Boster Bio’s A30637 ) confirm antibody specificity.

Limitations and Future Directions

Current antibodies lack explicit validation for mitochondrial-specific HPPK/DHPS. Structural modeling data suggest epitopes in the linker region (residues 161–202) could be targeted to develop isoform-selective antibodies. Proteomic studies using existing reagents have identified DHPS interactions with NF-κB pathway components, highlighting its therapeutic potential in metabolic diseases .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
MitHPPK/DHPS antibody; At4g30000 antibody; F6G3.30Folate synthesis bifunctional protein antibody; mitochondrial [Includes: 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase antibody; HPPK antibody; EC 2.7.6.3 antibody; 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase antibody; 7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase); Dihydropteroate synthase antibody; DHPS antibody; EC 2.5.1.15)] antibody
Target Names
MitHPPK/DHPS
Uniprot No.

Target Background

Function
This antibody targets MitHPPK/DHPS, an enzyme that catalyzes the first two consecutive steps of tetrahydrofolate biosynthesis.
Database Links

KEGG: ath:AT4G30000

STRING: 3702.AT4G30000.2

UniGene: At.31868

Protein Families
HPPK family; DHPS family
Subcellular Location
Mitochondrion.
Tissue Specificity
Ubiquitous.

Q&A

Here’s a structured FAQ guide for researchers working with DHPS (Deoxyhypusine Synthase) antibodies, based on academic research scenarios and curated from the provided sources:

Advanced Research Questions

How to resolve discrepancies in DHPS banding patterns across studies?

  • Approach:

    • Post-translational modifications: DHPS undergoes hypusination, altering electrophoretic mobility. Use enzymatic deglycosylation or phosphatase treatment .

    • Antibody clonality: Polyclonal antibodies (e.g., ab190266) may detect multiple isoforms, while monoclonal (e.g., 67998-1-Ig) show higher specificity .

    • Buffer optimization: Adjust SDS-PAGE conditions (e.g., 10–12% gels) to improve resolution of ~40 kDa bands .

What strategies enhance DHPS detection in low-abundance samples?

  • Signal amplification:

    MethodProtocol AdjustmentExample
    Enhanced WBUse 1:500–1:1000 dilutions with extended exposure (e.g., 3–10 min for ECL) .
    Multiplex IP-WBCombine IP-grade antibodies (e.g., 11184-1-AP at 0.5–4 µg/mg lysate) with high-sensitivity secondary reagents .

How to validate cross-species reactivity for DHPS antibodies?

  • Stepwise validation:

    • Sequence alignment: Confirm ≥90% homology in immunogen regions (e.g., human vs. mouse DHPS) .

    • Functional testing: Compare activity in spermidine-treated vs. untreated lysates across species .

    • Orthogonal validation: Pair antibody staining with mass spectrometry (e.g., LC-MS/MS) .

Data Table: DHPS Antibody Comparison

Antibody (Source)Host/ClonalityApplicationsSpecies ReactivityKey Validation Data
ab190266 Rabbit/polyclonalIP, WBHuman, MouseIP in HeLa lysates; 41 kDa band
67998-1-Ig Mouse/monoclonalWB, ELISAHumanDetects DHPS in HEK-293, Jurkat
11184-1-AP Rabbit/polyclonalWB, IP, IHCHuman, Mouse, Rat35–40 kDa band in NIH/3T3 cells
ab224134 Rabbit/polyclonalIHC-P, ICC/IFHumanValidated in IHC-P (aa 1–150)

Methodological Notes

  • Titration: Always optimize antibody dilutions (e.g., WB: 1:200–1:50,000) .

  • Storage: Maintain at -20°C in glycerol-containing buffers to prevent aggregation .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.